Liana Cuccia

Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · Journal of Cardiovascular Magnetic Resonance · 2013 · 138 citations · Full text

Medicine, Cardiology, Pharmacology +16

Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach

Alessia Pepe, Antonella Meloni, Giuseppe Rossi et al. · European Heart Journal - Cardiovascular Imaging · 2017 · 116 citations · Full text

Medicine, Cardiology, Radiology +17

Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Aurelio Maggio, Angela Vitrano, Marcello Capra et al. · Blood Cells Molecules and Diseases · 2009 · 96 citations

Medicine, Hematology, Pharmacology +6

Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major

Maddalena Casale, Antonella Meloni, Aldo Filosa et al. · Circulation Cardiovascular Imaging · 2015 · 79 citations · Full text

Medicine, Pediatrics, Radiology +14

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Aurelio Maggio, Antonis Kattamis, Mariagrazia Felisi et al. · The Lancet Haematology · 2020 · 72 citations

Medicine, Pediatrics, Pharmacology +11